| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | TRPM7 SPTA1 SPTAN1 FHOD3 TWF2 ADD3 BAIAP2L1 SVIL KCNMA1 MACF1 DIAPH3 UTRN | 1.02e-04 | 479 | 135 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | BICD2 TRPM7 CENPF SPTA1 SPTAN1 FHOD3 TWF2 SPAG9 KLC4 ADD3 DES BAIAP2L1 SVIL VPS41 KCNMA1 MACF1 DIAPH3 TRIM36 UTRN | 1.52e-04 | 1099 | 135 | 19 | GO:0008092 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.67e-06 | 89 | 132 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.66e-06 | 100 | 132 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 4.12e-06 | 144 | 132 | 8 | GO:0043244 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 4.49e-06 | 194 | 132 | 9 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 5.07e-06 | 105 | 132 | 7 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 5.08e-06 | 197 | 132 | 9 | GO:1902904 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 8.59e-06 | 75 | 132 | 6 | GO:0030837 | |
| GeneOntologyBiologicalProcess | actin filament capping | 1.10e-05 | 46 | 132 | 5 | GO:0051693 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 2.03e-05 | 52 | 132 | 5 | GO:0030835 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 2.62e-05 | 91 | 132 | 6 | GO:0032272 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 3.11e-05 | 190 | 132 | 8 | GO:0030041 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 3.98e-05 | 144 | 132 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 4.44e-05 | 61 | 132 | 5 | GO:0030834 | |
| GeneOntologyBiologicalProcess | protein polymerization | 5.90e-05 | 334 | 132 | 10 | GO:0051258 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 6.50e-05 | 66 | 132 | 5 | GO:0030042 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 6.61e-05 | 156 | 132 | 7 | GO:0030833 | |
| GeneOntologyBiologicalProcess | mucociliary clearance | 6.99e-05 | 13 | 132 | 3 | GO:0120197 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | BICD2 SPEF2 KLC4 NSUN7 NEFL RASGRP1 CFAP54 IFT52 CFAP221 DNAI2 VPS13A IFT80 | 7.93e-05 | 493 | 132 | 12 | GO:0007018 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | WAPL CENPF SPTA1 SPTAN1 BMERB1 FHOD3 TWF2 ADD3 RHPN2 SVIL DIAPH3 | 8.52e-05 | 421 | 132 | 11 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | BICD2 SPTA1 SPTAN1 BMERB1 FHOD3 TWF2 CAV1 ADD3 BAIAP2L1 RHPN2 SVIL DIAPH3 TRIM36 | 8.95e-05 | 579 | 132 | 13 | GO:0051493 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 9.32e-05 | 222 | 132 | 8 | GO:0008154 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTA1 SPTAN1 BMERB1 FHOD3 TWF2 CAV1 ADD3 BAIAP2L1 RHPN2 SVIL DIAPH3 | 1.21e-04 | 438 | 132 | 11 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 1.23e-04 | 231 | 132 | 8 | GO:0032271 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BICD2 SPEF2 BMERB1 CAV1 XPO1 KLC4 NSUN7 NEFL RASGRP1 CFAP54 IFT52 CFAP221 DNAI2 VPS13A MACF1 IFT80 DIAPH3 TRIM36 | 1.41e-04 | 1058 | 132 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 1.46e-04 | 177 | 132 | 7 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 1.62e-04 | 180 | 132 | 7 | GO:0030832 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.28e-04 | 253 | 132 | 8 | GO:0099111 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 2.70e-04 | 20 | 132 | 3 | GO:0090660 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | BICD2 WAPL CENPF SPTA1 SPTAN1 BMERB1 FHOD3 TWF2 CAV1 ADD3 VPS13D LMAN1 BAIAP2L1 RHPN2 SVIL DIAPH3 CDC6 EIF4G3 TRIM36 CNOT1 | 3.42e-04 | 1342 | 132 | 20 | GO:0033043 |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.01e-04 | 5 | 132 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SPTA1 SPTAN1 FHOD3 TWF2 ADD3 NEFL BAIAP2L1 SVIL KCNMA1 MACF1 | 4.22e-04 | 426 | 132 | 10 | GO:0032535 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | WAPL CENPF SPTA1 SPTAN1 PON1 BMERB1 FHOD3 TWF2 CAV1 ADD3 RHPN2 SACS SVIL LRPAP1 DIAPH3 | 4.26e-04 | 864 | 132 | 15 | GO:0051129 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 5.24e-04 | 438 | 132 | 10 | GO:0032970 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 5.80e-04 | 291 | 132 | 8 | GO:0032984 | |
| Domain | EF-hand-dom_pair | FLG SPEF2 SPTA1 SPTAN1 EFCAB2 TBC1D8B RASGRP1 DEF6 MACF1 PLCG2 CAPS2 UTRN | 7.29e-07 | 287 | 129 | 12 | IPR011992 |
| Domain | Spectrin | 1.74e-05 | 23 | 129 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 4.51e-05 | 29 | 129 | 4 | IPR002017 | |
| Domain | SPEC | 6.72e-05 | 32 | 129 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.72e-05 | 32 | 129 | 4 | IPR018159 | |
| Domain | - | 8.44e-05 | 261 | 129 | 9 | 1.10.238.10 | |
| Domain | DUF3496 | 1.41e-04 | 3 | 129 | 2 | IPR021885 | |
| Domain | VPS13 | 1.41e-04 | 3 | 129 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.41e-04 | 3 | 129 | 2 | PF16910 | |
| Domain | VPS13 | 1.41e-04 | 3 | 129 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.41e-04 | 3 | 129 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.41e-04 | 3 | 129 | 2 | IPR031642 | |
| Domain | DUF3496 | 1.41e-04 | 3 | 129 | 2 | PF12001 | |
| Domain | EF_HAND_2 | 2.05e-04 | 231 | 129 | 8 | PS50222 | |
| Domain | EF_hand_dom | 2.11e-04 | 232 | 129 | 8 | IPR002048 | |
| Domain | SHR-BD | 2.81e-04 | 4 | 129 | 2 | IPR009543 | |
| Domain | TRPM_tetra | 2.81e-04 | 4 | 129 | 2 | PF16519 | |
| Domain | VPS13_C | 2.81e-04 | 4 | 129 | 2 | PF16909 | |
| Domain | TRPM_tetra | 2.81e-04 | 4 | 129 | 2 | IPR032415 | |
| Domain | VPS13_C | 2.81e-04 | 4 | 129 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.81e-04 | 4 | 129 | 2 | PF06650 | |
| Domain | EFhand_Ca_insen | 6.97e-04 | 6 | 129 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 6.97e-04 | 6 | 129 | 2 | IPR014837 | |
| Domain | EFh | 8.06e-04 | 158 | 129 | 6 | SM00054 | |
| Domain | Cullin_CS | 9.72e-04 | 7 | 129 | 2 | IPR016157 | |
| Domain | Filament_head | 9.72e-04 | 7 | 129 | 2 | PF04732 | |
| Domain | CULLIN | 9.72e-04 | 7 | 129 | 2 | SM00182 | |
| Domain | Intermed_filament_DNA-bd | 9.72e-04 | 7 | 129 | 2 | IPR006821 | |
| Domain | DAD_dom | 1.29e-03 | 8 | 129 | 2 | IPR014767 | |
| Domain | Chorein_N | 1.29e-03 | 8 | 129 | 2 | PF12624 | |
| Domain | Cullin_neddylation_domain | 1.29e-03 | 8 | 129 | 2 | IPR019559 | |
| Domain | DAD | 1.29e-03 | 8 | 129 | 2 | PS51231 | |
| Domain | Cullin_Nedd8 | 1.29e-03 | 8 | 129 | 2 | PF10557 | |
| Domain | VPS13_N | 1.29e-03 | 8 | 129 | 2 | IPR026854 | |
| Domain | Cullin_Nedd8 | 1.29e-03 | 8 | 129 | 2 | SM00884 | |
| Domain | Cullin_homology | 1.65e-03 | 9 | 129 | 2 | IPR016158 | |
| Domain | Cullin | 2.05e-03 | 10 | 129 | 2 | PF00888 | |
| Domain | Anoctamin | 2.05e-03 | 10 | 129 | 2 | PF04547 | |
| Domain | Anoctamin | 2.05e-03 | 10 | 129 | 2 | IPR007632 | |
| Domain | CULLIN_2 | 2.05e-03 | 10 | 129 | 2 | PS50069 | |
| Domain | Cullin_N | 2.05e-03 | 10 | 129 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 2.05e-03 | 10 | 129 | 2 | PS01256 | |
| Domain | GBD/FH3_dom | 2.50e-03 | 11 | 129 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.50e-03 | 11 | 129 | 2 | PS51232 | |
| Domain | EF_HAND_1 | 2.95e-03 | 204 | 129 | 6 | PS00018 | |
| Domain | Cullin_repeat-like_dom | 2.99e-03 | 12 | 129 | 2 | IPR016159 | |
| Domain | G_SEPTIN_dom | 3.51e-03 | 13 | 129 | 2 | IPR030379 | |
| Domain | Septin | 3.51e-03 | 13 | 129 | 2 | PF00735 | |
| Domain | G_SEPTIN | 3.51e-03 | 13 | 129 | 2 | PS51719 | |
| Domain | Septin | 4.08e-03 | 14 | 129 | 2 | IPR016491 | |
| Domain | EF-hand_1 | 4.10e-03 | 152 | 129 | 5 | PF00036 | |
| Domain | FH2 | 4.69e-03 | 15 | 129 | 2 | PS51444 | |
| Domain | FH2_Formin | 4.69e-03 | 15 | 129 | 2 | IPR015425 | |
| Domain | FH2 | 4.69e-03 | 15 | 129 | 2 | PF02181 | |
| Domain | Spectrin_alpha_SH3 | 4.69e-03 | 15 | 129 | 2 | IPR013315 | |
| Domain | FH2 | 4.69e-03 | 15 | 129 | 2 | SM00498 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STARD13 UACA SPTAN1 CAV1 PREX2 ADD3 LMAN1 BAIAP2L1 RHPN2 DEF6 RNF20 ARHGAP29 DIAPH3 CKAP4 SOS1 | 5.32e-07 | 450 | 99 | 15 | M27078 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STARD13 SPTAN1 CAV1 PREX2 ADD3 LMAN1 BAIAP2L1 RHPN2 DEF6 RNF20 ARHGAP29 DIAPH3 CKAP4 SOS1 | 2.22e-06 | 439 | 99 | 14 | MM15595 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | STARD13 UACA CENPF SPTAN1 CAV1 XPO1 KLC4 PREX2 ADD3 LMAN1 BAIAP2L1 RHPN2 DEF6 RNF20 ARHGAP29 DIAPH3 CKAP4 SOS1 | 2.31e-06 | 720 | 99 | 18 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | STARD13 CENPF SPTAN1 CAV1 XPO1 KLC4 PREX2 ADD3 LMAN1 BAIAP2L1 RHPN2 DEF6 RNF20 ARHGAP29 DIAPH3 CKAP4 SOS1 | 2.46e-06 | 649 | 99 | 17 | MM15690 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 6.88e-06 | 142 | 99 | 8 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 9.81e-06 | 149 | 99 | 8 | M41805 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.28e-05 | 176 | 99 | 8 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.33e-05 | 183 | 99 | 8 | M997 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.90e-04 | 41 | 99 | 4 | MM15630 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 2.09e-04 | 42 | 99 | 4 | M41821 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.30e-04 | 175 | 99 | 7 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 3.12e-04 | 184 | 99 | 7 | M41809 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.62e-04 | 87 | 99 | 5 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.81e-04 | 88 | 99 | 5 | M41810 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 5.15e-04 | 53 | 99 | 4 | M41811 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 5.17e-04 | 94 | 99 | 5 | MM15598 | |
| Pubmed | DSC2 UACA TRPM7 PDZD11 SPTAN1 HEATR1 CAV1 ADD3 RRP1 DMXL1 PCF11 NOP58 LMAN1 SACS VPS13A PIP5K1A MACF1 LRPAP1 IFT80 DIAPH3 CKAP4 TRIM13 EIF4G3 TXLNG | 4.04e-09 | 1487 | 137 | 24 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B BICD2 KDM3A WAPL UACA SPTAN1 SPAG9 CHD7 XPO1 PCF11 SRRT PPIG UBN1 SVIL RNF20 DDX41 SOS1 | 1.19e-08 | 774 | 137 | 17 | 15302935 |
| Pubmed | SETX UACA PDZD11 PSMA4 SPTAN1 CHD7 TBC1D8B ITIH3 ADD3 RRP1 PCF11 ANKRD36B SRRT PPIG NOP58 RBM19 SVIL CKAP4 PIPSL DDX41 CNOT1 RSBN1L | 2.16e-08 | 1371 | 137 | 22 | 36244648 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CUL4A SETX DSC2 TRPM7 SPTAN1 KLC4 SRRT VPS13D BAIAP2L1 KIAA1217 SVIL IQCB1 MACF1 SH3BP5L EIF4G3 DDX41 UTRN | 5.54e-08 | 861 | 137 | 17 | 36931259 |
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 32704025 | ||
| Pubmed | CUL4B CENPF SPTAN1 SPAG9 CHD7 HEATR1 XPO1 RRP1 NEFL NOP58 MACF1 EIF4G3 UTRN CNOT1 | 3.35e-07 | 653 | 137 | 14 | 22586326 | |
| Pubmed | CUL4B BICD2 DSC2 TRPM7 SPTAN1 TWF2 SPAG9 ANO10 VPS13D LMAN1 VPS13A CKAP4 TRIM13 | 4.33e-07 | 568 | 137 | 13 | 37774976 | |
| Pubmed | 7.14e-07 | 250 | 137 | 9 | 33536335 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B CUL4A WAPL SETX CHD7 HEATR1 PCF11 SRRT NOP58 UBN1 RBM19 CKAP4 DDX41 TAF1L RSBN1L ILKAP | 1.21e-06 | 954 | 137 | 16 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG SETX SPTAN1 CHD7 XPO1 RRP1 PCF11 SRRT NEFL PPIG NOP58 SACS PCDH15 MACF1 CKAP4 DDX41 CNOT1 | 1.34e-06 | 1082 | 137 | 17 | 38697112 |
| Pubmed | 1.67e-06 | 277 | 137 | 9 | 30745168 | ||
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 1.69e-06 | 143 | 137 | 7 | 30397336 | |
| Pubmed | SPTAN1 KIAA1217 SVIL DEF6 RNF20 MACF1 CKAP4 SEPTIN10 UTRN TXLNG | 1.79e-06 | 360 | 137 | 10 | 33111431 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PIGN UACA CENPF SPTAN1 HEATR1 CAV1 XPO1 ADD3 RRP1 SRRT NOP58 BAIAP2L1 RBM19 KIAA1217 SVIL CKAP4 DDX41 RSBN1L | 2.37e-06 | 1257 | 137 | 18 | 36526897 |
| Pubmed | CUL4B CUL4A WAPL PSMA4 CASP1 CAV1 XPO1 RTF1 SRRT PPIG NOP58 RBM12 UBN1 RNF20 DDX41 ILKAP | 2.66e-06 | 1014 | 137 | 16 | 32416067 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.98e-06 | 394 | 137 | 10 | 27248496 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BICD2 BDP1 SETX TWF2 CHD7 UBN1 BAIAP2L1 KIAA1217 IQCB1 MACF1 SH3BP5L DIAPH3 | 3.99e-06 | 588 | 137 | 12 | 38580884 |
| Pubmed | GOLM2 SPTAN1 SPAG9 XPO1 PCF11 NEFL LMAN1 SVIL VPS13A KCNMA1 CKAP4 TRIM13 TRIM36 UTRN CNOT1 ILKAP | 4.09e-06 | 1049 | 137 | 16 | 27880917 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | BICD2 UACA SPTAN1 NOP58 RBM19 GTF2H5 PIP5K1A MACF1 DIAPH3 CKAP4 EIF4G3 CNOT1 TXLNG | 6.23e-06 | 724 | 137 | 13 | 36232890 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 WAPL SETX PSMA4 SPTAN1 CHD7 HEATR1 XPO1 SRRT NOP58 UBN1 RBM19 RNF20 MACF1 PLCG2 CKAP4 DDX41 UTRN | 6.53e-06 | 1353 | 137 | 18 | 29467282 |
| Pubmed | DSC2 UACA ADD3 ATP6V0D1 BAIAP2L1 KIAA1217 PIP5K1A MACF1 CKAP4 UTRN | 7.10e-06 | 421 | 137 | 10 | 36976175 | |
| Pubmed | 7.82e-06 | 253 | 137 | 8 | 29911972 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPF HEATR1 XPO1 RRP1 SRRT NOP58 IQCB1 MACF1 CKAP4 CDC6 EIF4G3 CNOT1 TXLNG | 1.03e-05 | 759 | 137 | 13 | 35915203 |
| Pubmed | KDM3A WAPL SPTAN1 TWF2 SPAG9 HEATR1 ADD3 NOP58 DIAPH3 CNOT1 RSBN1L | 1.21e-05 | 549 | 137 | 11 | 38280479 | |
| Pubmed | UACA SPTAN1 TWF2 HEATR1 CAV1 RRP1 SRRT PPIG NOP58 SVIL MACF1 SEPTIN10 | 1.27e-05 | 660 | 137 | 12 | 32780723 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.39e-05 | 197 | 137 | 7 | 20811636 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CUL4A SETX CENPF SPTA1 CHD7 E4F1 HEATR1 RRP1 SRRT PPIG NOP58 UBN1 RNF20 CKAP4 CDC6 DDX41 TAF1L | 1.42e-05 | 1294 | 137 | 17 | 30804502 |
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 1.54e-05 | 2 | 137 | 2 | 27974468 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17283063 | ||
| Pubmed | Binding of brain spectrin to the 70-kDa neurofilament subunit protein. | 1.54e-05 | 2 | 137 | 2 | 3121319 | |
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 1.54e-05 | 2 | 137 | 2 | 25830635 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 2939097 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24360193 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20064923 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24705869 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 21162838 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | UACA SPTAN1 TWF2 ADD3 BAIAP2L1 KIAA1217 SVIL ARHGAP29 MACF1 DIAPH3 UTRN | 1.58e-05 | 565 | 137 | 11 | 25468996 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4B STARD13 CUL4A FLG PDZD11 SPAG9 HEATR1 KLC4 NEFL IFT52 LMAN1 IQCB1 IFT80 DDX41 CNOT1 TXLNG CCDC144A | 1.84e-05 | 1321 | 137 | 17 | 27173435 |
| Pubmed | 2.03e-05 | 209 | 137 | 7 | 36779422 | ||
| Pubmed | 2.63e-05 | 15 | 137 | 3 | 37091236 | ||
| Pubmed | 2.93e-05 | 304 | 137 | 8 | 32235678 | ||
| Pubmed | KDM3A SETX PSMA4 CASP1 TWF2 CHD7 XPO1 PCF11 NOP58 RBM12 LMAN1 SEPTIN14 DDX41 CNOT1 TXLNG | 3.17e-05 | 1103 | 137 | 15 | 34189442 | |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 3.23e-05 | 16 | 137 | 3 | 29878059 | |
| Pubmed | 3.26e-05 | 225 | 137 | 7 | 12168954 | ||
| Pubmed | 3.68e-05 | 408 | 137 | 9 | 33766124 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 19176762 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 32684624 | ||
| Pubmed | Modulation of integrin-linked kinase nucleo-cytoplasmic shuttling by ILKAP and CRM1. | 4.61e-05 | 3 | 137 | 2 | 18635968 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 32587774 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 34766662 | ||
| Pubmed | Interaction domains of neurofilament light chain and brain spectrin. | 4.61e-05 | 3 | 137 | 2 | 1902666 | |
| Pubmed | Caveolae Link CaV3.2 Channels to BKCa-Mediated Feedback in Vascular Smooth Muscle. | 4.61e-05 | 3 | 137 | 2 | 30354206 | |
| Pubmed | Human Asunder promotes dynein recruitment and centrosomal tethering to the nucleus at mitotic entry. | 4.61e-05 | 3 | 137 | 2 | 23097494 | |
| Pubmed | Targeted Sos1 deletion reveals its critical role in early T-cell development. | 4.61e-05 | 3 | 137 | 2 | 21746917 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 25427726 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 34119472 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26620773 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 33036707 | ||
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 4.61e-05 | 3 | 137 | 2 | 2971657 | |
| Pubmed | Cullin4B/E3-ubiquitin ligase negatively regulates beta-catenin. | 4.61e-05 | 3 | 137 | 2 | 17954973 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22586275 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 34472763 | ||
| Pubmed | E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation. | 4.61e-05 | 3 | 137 | 2 | 24452595 | |
| Pubmed | 4.63e-05 | 162 | 137 | 6 | 15174051 | ||
| Pubmed | BICD2 KDM3A WAPL TRPM7 ACO1 SPTAN1 ADD3 NEFL SACS MACF1 LRPAP1 EIF4G3 UTRN TXLNG RSBN1L SOS1 | 4.89e-05 | 1285 | 137 | 16 | 35914814 | |
| Pubmed | 5.40e-05 | 102 | 137 | 5 | 11214970 | ||
| Pubmed | STARD13 FLG CENPF SPEF2 SPTA1 SPTAN1 HEATR1 PCF11 DES NEFL SACS CAPRIN2 VPS13A MACF1 DIAPH3 EIF4G3 SEPTIN10 | 5.51e-05 | 1442 | 137 | 17 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CENPF HEATR1 XPO1 RRP1 SRRT NEFL NOP58 SACS SVIL MACF1 CKAP4 DDX41 UTRN CNOT1 | 5.56e-05 | 1024 | 137 | 14 | 24711643 |
| Pubmed | 6.05e-05 | 170 | 137 | 6 | 15057823 | ||
| Pubmed | PIGN KDM3A HEATR1 ANO10 XPO1 ITGAX NOP58 LMAN1 ATP11B PLXNC1 RBM19 DEF6 DDX41 CNOT1 MAN1B1 | 6.05e-05 | 1168 | 137 | 15 | 19946888 | |
| Pubmed | SETX DSC2 TRPM7 SPAG9 CAV1 ADD3 DMXL1 PCF11 BAIAP2L1 RBM19 VPS13A EIF4G3 | 6.19e-05 | 777 | 137 | 12 | 35844135 | |
| Pubmed | 6.49e-05 | 20 | 137 | 3 | 18723693 | ||
| Pubmed | STARD13 PDZD11 HEATR1 XPO1 PREX2 SRRT NEFL NOP58 ARHGAP29 LRPAP1 CKAP4 UTRN SOS1 | 7.15e-05 | 916 | 137 | 13 | 32203420 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | HEATR1 RRP1 SRRT PPIG NOP58 RBM12 RBM19 MACF1 CKAP4 EIF4G3 DDX41 CNOT1 | 8.86e-05 | 807 | 137 | 12 | 22681889 |
| Pubmed | Regulation of systemic autoimmunity and CD11c+ Tbet+ B cells by SWEF proteins. | 9.19e-05 | 4 | 137 | 2 | 28780965 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 24222714 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 10551855 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 25445355 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 36997670 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 12571280 | ||
| Pubmed | TNF stimulates nuclear export and secretion of IL-15 by acting on CRM1 and ARF6. | 9.19e-05 | 4 | 137 | 2 | 23950892 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 9593709 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 30945295 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 32034489 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 15498460 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 34420308 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 19818632 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 9.19e-05 | 4 | 137 | 2 | 3862089 | |
| Pubmed | Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2. | 9.19e-05 | 4 | 137 | 2 | 12049649 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 22163289 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 21522132 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 22453236 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 9.19e-05 | 4 | 137 | 2 | 12820899 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 22262661 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 9.79e-05 | 268 | 137 | 7 | 33024031 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ACO1 PSMA4 TWF2 ANO10 CAV1 XPO1 RRP1 NOP58 ATP6V0D1 LMAN1 BAIAP2L1 RBM19 PIP5K1A UTRN CNOT1 ILKAP | 1.01e-04 | 1367 | 137 | 16 | 32687490 |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.08e-04 | 118 | 137 | 5 | 27377895 | |
| Pubmed | 1.08e-04 | 118 | 137 | 5 | 30979931 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.09e-04 | 582 | 137 | 10 | 20467437 | |
| Interaction | RAB35 interactions | DSC2 UACA TRPM7 SPTAN1 CAV1 ADD3 DMXL1 LMAN1 BAIAP2L1 IQCB1 VPS13A PIP5K1A MACF1 DIAPH3 CKAP4 TRIM13 UTRN | 2.96e-07 | 573 | 135 | 17 | int:RAB35 |
| Interaction | RHOF interactions | DSC2 UACA TRPM7 PDZD11 SPTAN1 CAV1 XPO1 ADD3 GSTT1 LMAN1 BAIAP2L1 VPS13A PIP5K1A MACF1 DIAPH3 CKAP4 SEPTIN10 UTRN | 5.87e-07 | 673 | 135 | 18 | int:RHOF |
| Interaction | RAC3 interactions | DSC2 UACA TRPM7 PDZD11 SPTAN1 CAV1 ADD3 LMAN1 BAIAP2L1 KIAA1217 VPS13A PIP5K1A MACF1 DIAPH3 CKAP4 TRIM13 UTRN | 8.64e-07 | 619 | 135 | 17 | int:RAC3 |
| Interaction | RND3 interactions | DSC2 TRPM7 PDZD11 SPTAN1 HEATR1 CAV1 ADD3 SRRT BAIAP2L1 KIAA1217 CKAP4 | 2.34e-06 | 273 | 135 | 11 | int:RND3 |
| Interaction | KRT18 interactions | BICD2 FLG TRPM7 CASP1 CAV1 DES NEFL RHPN2 KIAA1217 SVIL IQCB1 TRIM36 CNOT1 | 4.97e-06 | 419 | 135 | 13 | int:KRT18 |
| Interaction | KIF20A interactions | SETX UACA SPTAN1 SPAG9 HEATR1 LRRK1 CAV1 XPO1 TBC1D8B DES NEFL NOP58 RBM19 SVIL MACF1 ANKRD18A SH3BP5L PLCG2 CKAP4 SEPTIN10 UTRN | 6.83e-06 | 1052 | 135 | 21 | int:KIF20A |
| Interaction | RAC1 interactions | DSC2 TRPM7 PDZD11 SPTAN1 CAV1 XPO1 PREX2 ADD3 LMAN1 BAIAP2L1 IQCB1 DEF6 VPS13A PIP5K1A MACF1 HABP2 DIAPH3 CKAP4 SEPTIN10 UTRN SOS1 | 8.01e-06 | 1063 | 135 | 21 | int:RAC1 |
| Interaction | C11orf52 interactions | DSC2 UACA SPTAN1 LRRK1 CAV1 XPO1 ADD3 BAIAP2L1 PIP5K1A MACF1 UTRN | 8.12e-06 | 311 | 135 | 11 | int:C11orf52 |
| Interaction | ABL1 interactions | 9.96e-06 | 259 | 135 | 10 | int:ABL1 | |
| Interaction | RAC2 interactions | DSC2 TRPM7 PDZD11 SPTAN1 CAV1 ADD3 VPS13D LMAN1 BAIAP2L1 DEF6 VPS13A PIP5K1A MACF1 DIAPH3 CKAP4 UTRN | 1.18e-05 | 674 | 135 | 16 | int:RAC2 |
| Interaction | RHOJ interactions | DSC2 TRPM7 PDZD11 SPTAN1 CAV1 ADD3 LMAN1 BAIAP2L1 VPS13A PIP5K1A MACF1 DIAPH3 CKAP4 SEPTIN10 UTRN | 2.29e-05 | 633 | 135 | 15 | int:RHOJ |
| Interaction | LYN interactions | DSC2 UACA SPTAN1 CAV1 ADD3 LMAN1 BAIAP2L1 KIAA1217 SVIL TGDS VPS13A PIP5K1A MACF1 PLCG2 UTRN BANK1 | 2.64e-05 | 720 | 135 | 16 | int:LYN |
| Interaction | RHOD interactions | DSC2 TRPM7 ADCK5 SPTAN1 CAV1 ADD3 LMAN1 BAIAP2L1 VPS13A MACF1 DIAPH3 CKAP4 SEPTIN10 UTRN | 3.07e-05 | 572 | 135 | 14 | int:RHOD |
| Interaction | GJA1 interactions | DSC2 UACA TRPM7 SPTAN1 CAV1 ADD3 LMAN1 KIAA1217 VPS13A PIP5K1A MACF1 CKAP4 TRIM13 UTRN | 3.78e-05 | 583 | 135 | 14 | int:GJA1 |
| Interaction | KRT8 interactions | BICD2 UACA CASP1 CAV1 KLC4 DES NEFL IQCB1 DIAPH3 SEPTIN10 TRIM36 CNOT1 | 4.24e-05 | 441 | 135 | 12 | int:KRT8 |
| Interaction | MAPRE1 interactions | BICD2 SPTAN1 XPO1 ADD3 PPIG IFT52 KIAA1217 SVIL IQCB1 MACF1 DIAPH3 TRIM36 CNOT1 | 4.28e-05 | 514 | 135 | 13 | int:MAPRE1 |
| Interaction | UBA2 interactions | 5.31e-05 | 253 | 135 | 9 | int:UBA2 | |
| Interaction | EFNB1 interactions | 5.64e-05 | 255 | 135 | 9 | int:EFNB1 | |
| Interaction | CDC42 interactions | CUL4A DSC2 TRPM7 ACO1 SPTAN1 HEATR1 CAV1 XPO1 PREX2 ADD3 LMAN1 BAIAP2L1 DEF6 VPS13A ARHGAP29 PLCG2 DIAPH3 CKAP4 TRIM13 SEPTIN10 UTRN CNOT1 | 6.70e-05 | 1323 | 135 | 22 | int:CDC42 |
| Interaction | NUCB1 interactions | 7.16e-05 | 104 | 135 | 6 | int:NUCB1 | |
| Interaction | YWHAG interactions | CUL4A DSC2 UACA TRPM7 PDZD11 SPTAN1 XPO1 KLC4 NEFL PPIG VPS13D BAIAP2L1 RHPN2 SVIL KCNMA1 ARHGAP29 MACF1 SH3BP5L EIF4G3 DDX41 UTRN | 8.47e-05 | 1248 | 135 | 21 | int:YWHAG |
| Interaction | EED interactions | CUL4B CUL4A SETX SPTAN1 TWF2 CHD7 HEATR1 XPO1 DMXL1 SRRT NOP58 ATP6V0D1 RHPN2 RBM19 SVIL VPS41 KCNMA1 MACF1 LRPAP1 CKAP4 DDX41 CNOT1 MAN1B1 | 8.71e-05 | 1445 | 135 | 23 | int:EED |
| Interaction | TANK interactions | 1.06e-04 | 216 | 135 | 8 | int:TANK | |
| Interaction | HRAS interactions | CUL4A DSC2 UACA TRPM7 SPTA1 SPTAN1 CAV1 ADD3 RASGRP1 BAIAP2L1 RHPN2 ARHGAP29 PIP5K1A DIAPH3 SOS1 | 1.06e-04 | 725 | 135 | 15 | int:HRAS |
| Interaction | LAMP1 interactions | CUL4A DSC2 TRPM7 SPTAN1 CAV1 ADD3 ATP6V0D1 LMAN1 BAIAP2L1 PIP5K1A MACF1 CKAP4 TRIM13 PIPSL | 1.09e-04 | 644 | 135 | 14 | int:LAMP1 |
| Interaction | YWHAH interactions | SETX DSC2 UACA TRPM7 SPTAN1 XPO1 KLC4 SRRT VPS13D BAIAP2L1 RHPN2 KIAA1217 SVIL IQCB1 KCNMA1 MACF1 SH3BP5L EIF4G3 UTRN | 1.40e-04 | 1102 | 135 | 19 | int:YWHAH |
| Interaction | SIRT7 interactions | CUL4B CUL4A CENPF SPTAN1 SPAG9 CHD7 HEATR1 XPO1 RRP1 NEFL NOP58 MACF1 EIF4G3 UTRN CNOT1 | 1.41e-04 | 744 | 135 | 15 | int:SIRT7 |
| Interaction | CAPN2 interactions | 1.45e-04 | 169 | 135 | 7 | int:CAPN2 | |
| Interaction | ADD1 interactions | 1.56e-04 | 171 | 135 | 7 | int:ADD1 | |
| Interaction | RHOB interactions | DSC2 UACA TRPM7 SPTAN1 CAV1 XPO1 ADD3 LMAN1 BAIAP2L1 RHPN2 VPS13A ARHGAP29 PIP5K1A MACF1 DIAPH3 UTRN | 1.61e-04 | 840 | 135 | 16 | int:RHOB |
| Interaction | PLEKHA5 interactions | 1.68e-04 | 231 | 135 | 8 | int:PLEKHA5 | |
| Interaction | RHOH interactions | DSC2 UACA TRPM7 SPTAN1 CAV1 ADD3 VPS13D LMAN1 BAIAP2L1 VPS13A CKAP4 TRIM13 | 1.74e-04 | 512 | 135 | 12 | int:RHOH |
| Interaction | ATG12 interactions | 1.75e-04 | 296 | 135 | 9 | int:ATG12 | |
| Interaction | ARHGAP1 interactions | 1.78e-04 | 233 | 135 | 8 | int:ARHGAP1 | |
| Interaction | RHOQ interactions | DSC2 TRPM7 SPTAN1 CAV1 ADD3 DMXL1 BAIAP2L1 VPS13A PIP5K1A DIAPH3 UTRN | 1.95e-04 | 442 | 135 | 11 | int:RHOQ |
| Interaction | SLAIN2 interactions | 1.97e-04 | 125 | 135 | 6 | int:SLAIN2 | |
| Interaction | ATOH1 interactions | 2.01e-04 | 80 | 135 | 5 | int:ATOH1 | |
| Interaction | STX6 interactions | DSC2 GOLM2 SPTAN1 CAV1 ADD3 DMXL1 LMAN1 MACF1 DIAPH3 CKAP4 UTRN | 2.19e-04 | 448 | 135 | 11 | int:STX6 |
| Interaction | PPARG interactions | 2.30e-04 | 307 | 135 | 9 | int:PPARG | |
| Interaction | BCR interactions | 2.43e-04 | 244 | 135 | 8 | int:BCR | |
| Interaction | TNIK interactions | BICD2 CENPF SPTAN1 CAV1 XPO1 KIAA1217 KCNMA1 MACF1 ARRDC3 SOS1 | 2.51e-04 | 381 | 135 | 10 | int:TNIK |
| Interaction | SNAP29 interactions | 2.57e-04 | 246 | 135 | 8 | int:SNAP29 | |
| Interaction | TTC41P interactions | 2.65e-04 | 4 | 135 | 2 | int:TTC41P | |
| Interaction | ERC1 interactions | 2.70e-04 | 187 | 135 | 7 | int:ERC1 | |
| Interaction | NEFM interactions | 2.97e-04 | 190 | 135 | 7 | int:NEFM | |
| Interaction | SEPTIN8 interactions | 2.98e-04 | 87 | 135 | 5 | int:SEPTIN8 | |
| Interaction | ANKRD29 interactions | 3.08e-04 | 20 | 135 | 3 | int:ANKRD29 | |
| Interaction | IFT22 interactions | 3.23e-04 | 49 | 135 | 4 | int:IFT22 | |
| Interaction | VIM interactions | CUL4B BICD2 UACA SPEF2 SPTAN1 XPO1 SRRT DES NEFL VPS13D SACS KIAA1217 SVIL KCNMA1 TRIM36 | 3.25e-04 | 804 | 135 | 15 | int:VIM |
| Interaction | EPHA2 interactions | DSC2 UACA CAV1 ADD3 ATP6V0D1 LMAN1 BAIAP2L1 KIAA1217 PIP5K1A MACF1 ARRDC3 CKAP4 UTRN ILKAP | 3.39e-04 | 719 | 135 | 14 | int:EPHA2 |
| Interaction | BRWD3 interactions | 3.49e-04 | 50 | 135 | 4 | int:BRWD3 | |
| Interaction | CDCA5 interactions | 3.64e-04 | 140 | 135 | 6 | int:CDCA5 | |
| Interaction | EPB41L4A interactions | 3.64e-04 | 140 | 135 | 6 | int:EPB41L4A | |
| Interaction | DMD interactions | 3.78e-04 | 141 | 135 | 6 | int:DMD | |
| Interaction | COMTD1 interactions | 4.05e-04 | 200 | 135 | 7 | int:COMTD1 | |
| Interaction | RHOA interactions | DSC2 TRPM7 SPTAN1 HEATR1 CAV1 PREX2 ADD3 VPS13D LMAN1 BAIAP2L1 RHPN2 DEF6 VPS13A ARHGAP29 MACF1 DIAPH3 CKAP4 TRIM13 UTRN | 4.06e-04 | 1199 | 135 | 19 | int:RHOA |
| Interaction | ENTHD1 interactions | 4.12e-04 | 22 | 135 | 3 | int:ENTHD1 | |
| Cytoband | 12q23.3 | 1.59e-04 | 35 | 137 | 3 | 12q23.3 | |
| GeneFamily | EF-hand domain containing | 1.05e-05 | 219 | 87 | 8 | 863 | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.73e-04 | 7 | 87 | 2 | 1113 | |
| GeneFamily | Cullins | 6.29e-04 | 8 | 87 | 2 | 1032 | |
| GeneFamily | Anoctamins | 1.00e-03 | 10 | 87 | 2 | 865 | |
| GeneFamily | Ankyrin repeat domain containing | 1.11e-03 | 242 | 87 | 6 | 403 | |
| GeneFamily | Septins | 1.72e-03 | 13 | 87 | 2 | 732 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.90e-03 | 51 | 87 | 3 | 870 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL4B BDP1 SETX PSMA4 ZNF407 XPO1 ADD3 DMXL1 PPIG SACS PLXNC1 RAD54B CAPRIN2 RNF20 VPS41 DIAPH3 | 3.20e-07 | 656 | 136 | 16 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 KDM3A WAPL SETX CENPF BMERB1 SPAG9 XPO1 PCF11 ATP11B SACS VPS13A ARHGAP29 PIP5K1A MACF1 EIF4G3 SOS1 | 2.27e-06 | 856 | 136 | 17 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 7.61e-06 | 137 | 136 | 7 | M39241 | |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | 7.87e-06 | 193 | 136 | 8 | M4961 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_DN | 9.84e-06 | 199 | 136 | 8 | M3800 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | FHOD3 XPO1 ANKRD36C TBC1D8B PREX2 ADD3 ANKRD36B RASGRP1 RBM12 P2RX5 RAD54B TXLNG BANK1 | 1.22e-05 | 587 | 136 | 13 | M40869 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.46e-05 | 295 | 136 | 9 | M39121 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BICD2 BDP1 WAPL SETX SPEF2 SPTAN1 CASP1 TWF2 XPO1 PCF11 RASGRP1 PPIG RBM12 ATP11B P2RX5 SACS DEF6 MACF1 UTRN CNOT1 SOS1 | 2.86e-05 | 1492 | 136 | 21 | M40023 |
| Coexpression | GHO_ATF5_TARGETS_UP | 3.76e-05 | 13 | 136 | 3 | M12008 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CUL4B CUL4A WAPL SETX EFCAB2 SPAG9 XPO1 ADD3 DMXL1 PPIG IFT52 SACS PLXNC1 VPS41 GTF2H5 MACF1 CNOT1 BANK1 | 5.90e-05 | 1215 | 136 | 18 | M41122 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | CUL4A BDP1 PSMA4 ADD3 DMXL1 ANKRD36B RASGRP1 PPIG NOP58 LMAN1 SACS TMEM87B IFT80 | 6.21e-05 | 687 | 136 | 13 | M41022 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | BICD2 SPTAN1 CASP1 BMERB1 CHD7 DMXL1 SACS PLXNC1 RAD54B CAPRIN2 MACF1 EIF4G3 SEPTIN10 SOS1 | 6.49e-05 | 790 | 136 | 14 | M12490 |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 7.13e-05 | 194 | 136 | 7 | M4943 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 7.85e-05 | 197 | 136 | 7 | M5378 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 8.63e-05 | 200 | 136 | 7 | M5529 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 1.17e-04 | 282 | 136 | 8 | MM3642 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CUL4B PIGN KDM3A IL15 WAPL DSC2 BMERB1 CHD7 CAV1 ADD3 PCF11 RASGRP1 PLXNC1 CAPRIN2 ARHGAP29 TRIM13 UTRN CNOT1 SOS1 | 8.06e-07 | 803 | 135 | 19 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | CUL4B RBM44 WAPL SETX CENPF EFCAB2 HEATR1 ATP11B RHPN2 IQCB1 RAD54B CAPRIN2 VPS13A NDUFAF6 PLCG2 DIAPH3 TRIM13 TXLNG SMC1B | 1.14e-06 | 822 | 135 | 19 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | RBM44 BMERB1 DMXL1 RASGRP1 ATP11B SACS CAPRIN2 ARHGAP29 CAPS2 SMC1B | 1.42e-06 | 219 | 135 | 10 | gudmap_developingGonad_e16.5_ovary_1000_k5 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | CUL4B RBM44 CENPF HEATR1 RHPN2 IQCB1 RAD54B CAPRIN2 NDUFAF6 PLCG2 TRIM13 TXLNG SMC1B | 2.00e-06 | 406 | 135 | 13 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | RBM44 TRPM7 SPTA1 BMERB1 ADD3 DMXL1 RASGRP1 UBN1 ATP11B SACS PLXNC1 CAPRIN2 VPS41 ARHGAP29 PIP5K1A CAPS2 UTRN SMC1B | 3.00e-06 | 795 | 135 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | RBM44 CENPF EFCAB2 ATP11B RHPN2 IQCB1 RAD54B CAPRIN2 VPS13A PLCG2 TXLNG SMC1B | 6.64e-06 | 385 | 135 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CUL4B RBM44 WAPL SETX CENPF EFCAB2 HEATR1 ATP11B RHPN2 IQCB1 RAD54B CAPRIN2 NDUFAF6 PLCG2 TRIM13 TXLNG SMC1B | 1.22e-05 | 795 | 135 | 17 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CUL4B RBM44 SETX CENPF EFCAB2 HEATR1 DMXL1 ATP11B RHPN2 IQCB1 RAD54B CAPRIN2 VPS13A PLCG2 DIAPH3 TXLNG SMC1B | 1.81e-05 | 820 | 135 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RBM44 WAPL SETX CENPF EFCAB2 HEATR1 RHPN2 RAD54B CAPRIN2 NDUFAF6 PLCG2 DIAPH3 CDC6 TRIM13 TXLNG SMC1B | 3.75e-05 | 781 | 135 | 16 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | SETX CHD7 ADD3 RASGRP1 ATP11B ARHGAP29 MACF1 IFT80 LY75 UTRN | 4.71e-05 | 327 | 135 | 10 | GSM538380_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PIGN KDM3A WAPL DSC2 CAV1 ADD3 PCF11 RASGRP1 CFAP54 SACS PLXNC1 CAPRIN2 ARHGAP29 LY75 CNOT1 SMC1B | 5.30e-05 | 804 | 135 | 16 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 5.91e-05 | 336 | 135 | 10 | GSM538413_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_500 | 8.55e-05 | 113 | 135 | 6 | gudmap_developingGonad_e16.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.14e-04 | 230 | 135 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.24e-04 | 76 | 135 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.25e-04 | 233 | 135 | 8 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 WAPL SETX CENPF SPTAN1 FHOD3 CHD7 PREX2 PCF11 PLXNC1 CNOT1 TXLNG | 1.53e-04 | 532 | 135 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | CUL4B RBM44 WAPL SETX CENPF HEATR1 RHPN2 RAD54B CAPRIN2 NDUFAF6 PLCG2 DIAPH3 TRIM13 TXLNG SMC1B | 1.74e-04 | 799 | 135 | 15 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 WAPL SETX UACA CENPF CHD7 PREX2 DMXL1 PCF11 NOP58 CNOT1 | 2.08e-04 | 469 | 135 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 2.18e-04 | 134 | 135 | 6 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.57e-04 | 259 | 135 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 ZNF407 CHD7 HEATR1 XPO1 ADD3 RTF1 PPIG RNF20 MACF1 UTRN SOS1 | 2.62e-04 | 564 | 135 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | CUL4B KDM3A IL15 DSC2 CHD7 PCF11 RASGRP1 PLXNC1 ARHGAP29 CNOT1 | 2.65e-04 | 404 | 135 | 10 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_500 | 2.89e-04 | 91 | 135 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k5 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 3.18e-04 | 338 | 135 | 9 | GSM403987_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.23e-04 | 268 | 135 | 8 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CUL4B BDP1 WAPL SETX TTC41P TRPM7 CENPF BMERB1 FHOD3 CHD7 HEATR1 XPO1 PREX2 PPIG NOP58 IQCB1 RAD54B RNF20 VPS13A MACF1 SOS1 | 3.54e-04 | 1459 | 135 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200 | 3.59e-04 | 147 | 135 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CUL4B BDP1 WAPL SETX TTC41P TRPM7 CENPF BMERB1 FHOD3 HEATR1 XPO1 PPIG NOP58 IQCB1 RAD54B RNF20 VPS13A MACF1 SOS1 | 3.82e-04 | 1257 | 135 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | WAPL SETX TTC41P TRPM7 CENPF BMERB1 FHOD3 CHD7 HEATR1 NEFL PPIG CFAP54 RAD54B CAPRIN2 VPS13A MACF1 SH3BP5L | 4.07e-04 | 1060 | 135 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RBM44 BMERB1 ADD3 DMXL1 RASGRP1 SACS IQCB1 VPS13A ARHGAP29 PIP5K1A CAPS2 UTRN TXLNG SMC1B | 4.32e-04 | 776 | 135 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.43e-04 | 281 | 135 | 8 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | 4.73e-04 | 357 | 135 | 9 | GSM403986_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.13e-04 | 361 | 135 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CUL4B PIGN KDM3A IL15 DSC2 BMERB1 CHD7 PCF11 RASGRP1 PLXNC1 ARHGAP29 PIP5K1A CNOT1 SOS1 | 5.22e-04 | 791 | 135 | 14 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | BDP1 CENPF BMERB1 CHD7 CAV1 PREX2 PPIG LMAN1 UBN1 TMEM87B MACF1 LRPAP1 SH3BP5L IFT80 ARRDC3 UTRN | 5.30e-04 | 985 | 135 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 5.85e-04 | 224 | 135 | 7 | GSM403994_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | CUL4B RBM44 DSC2 TRPM7 BMERB1 DMXL1 NEFL PLXNC1 KIAA1217 ARHGAP29 PIP5K1A CAPS2 UTRN SMC1B | 6.13e-04 | 804 | 135 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.73e-04 | 375 | 135 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | 6.86e-04 | 376 | 135 | 9 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 7.67e-04 | 382 | 135 | 9 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_100 | 8.14e-04 | 29 | 135 | 3 | gudmap_developingGonad_e16.5_ovary_100_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_200 | 8.14e-04 | 29 | 135 | 3 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | 8.26e-04 | 386 | 135 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | 8.41e-04 | 387 | 135 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | STARD13 UACA SPTAN1 CASP1 SPAG9 CHD7 CAV1 PREX2 SACS ARHGAP29 MACF1 PLCG2 UTRN SMC1B | 8.44e-04 | 831 | 135 | 14 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.46e-04 | 115 | 135 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 9.29e-04 | 68 | 135 | 4 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k1_500 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SETX UACA SPEF2 SPTAN1 CHD7 CAV1 PREX2 ADD3 KIAA1217 ARHGAP29 MACF1 UTRN | 1.46e-12 | 200 | 137 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SETX UACA SPEF2 SPTAN1 CAV1 PREX2 ADD3 KIAA1217 ARHGAP29 MACF1 UTRN | 3.30e-11 | 200 | 137 | 11 | a2b9d1cd291d17abddc3ee2e242121412c864b8b |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | SETX UACA SPEF2 SPTAN1 CAV1 PREX2 ADD3 KIAA1217 ARHGAP29 MACF1 | 6.75e-10 | 200 | 137 | 10 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-08 | 200 | 137 | 9 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-07 | 190 | 137 | 8 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.95e-07 | 199 | 137 | 8 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.51e-07 | 169 | 137 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.80e-06 | 186 | 137 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-06 | 190 | 137 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 194 | 137 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-06 | 194 | 137 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.47e-06 | 195 | 137 | 7 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.64e-06 | 197 | 137 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.91e-06 | 200 | 137 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-06 | 200 | 137 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 166 | 137 | 6 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-05 | 174 | 137 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Large_pre-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 176 | 137 | 6 | 78417a5ac2e45e97e7b4c56c78c25879a1b58f97 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 1.83e-05 | 177 | 137 | 6 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 179 | 137 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-05 | 181 | 137 | 6 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 181 | 137 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-05 | 181 | 137 | 6 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 182 | 137 | 6 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.20e-05 | 183 | 137 | 6 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 2.27e-05 | 184 | 137 | 6 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 2.27e-05 | 184 | 137 | 6 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.42e-05 | 186 | 137 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 189 | 137 | 6 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-05 | 191 | 137 | 6 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-05 | 191 | 137 | 6 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.89e-05 | 192 | 137 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.97e-05 | 193 | 137 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 193 | 137 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-05 | 193 | 137 | 6 | 3a9fe4e709c09ec787c71bdd6b58a71c419896de | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 193 | 137 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.97e-05 | 193 | 137 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 3.06e-05 | 194 | 137 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.06e-05 | 194 | 137 | 6 | 22b87fe2bb84632ddcef8f1d7742021728e2246d | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 3.06e-05 | 194 | 137 | 6 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.06e-05 | 194 | 137 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.06e-05 | 194 | 137 | 6 | 6a0cbb9d5c5c4effb02dff654c6c3b184026875c | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 3.06e-05 | 194 | 137 | 6 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 194 | 137 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 3.15e-05 | 195 | 137 | 6 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.15e-05 | 195 | 137 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.24e-05 | 196 | 137 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.24e-05 | 196 | 137 | 6 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.24e-05 | 196 | 137 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.24e-05 | 196 | 137 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 3.33e-05 | 197 | 137 | 6 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.33e-05 | 197 | 137 | 6 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.33e-05 | 197 | 137 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.43e-05 | 198 | 137 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-05 | 198 | 137 | 6 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-05 | 199 | 137 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 3.53e-05 | 199 | 137 | 6 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 137 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.53e-05 | 199 | 137 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.53e-05 | 199 | 137 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-05 | 139 | 137 | 5 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.21e-04 | 156 | 137 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 160 | 137 | 5 | 741e3b3f4ec5c77752da54746451f332435226e3 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 167 | 137 | 5 | 53e32d6687a07f486141df9f4ab998af4c03a507 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 168 | 137 | 5 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 168 | 137 | 5 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-04 | 169 | 137 | 5 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-04 | 169 | 137 | 5 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 170 | 137 | 5 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 170 | 137 | 5 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 170 | 137 | 5 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.81e-04 | 170 | 137 | 5 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 1.86e-04 | 171 | 137 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.86e-04 | 171 | 137 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-04 | 171 | 137 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 137 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-05 | 49 | 74 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Clorgyline | 7.44e-06 | 168 | 135 | 8 | ctd:D003010 | |
| Drug | plakin | 9.40e-06 | 82 | 135 | 6 | CID000018752 | |
| Drug | AC1L231D | 1.12e-05 | 8 | 135 | 3 | CID000065316 | |
| Drug | FK-156 | 1.15e-05 | 24 | 135 | 4 | CID000122001 | |
| Disease | Hyperhomocysteinemia | 1.44e-05 | 11 | 133 | 3 | C0598608 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | primary open angle glaucoma (is_implicated_in) | 1.48e-04 | 23 | 133 | 3 | DOID:1070 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | BDP1 IL15 TRPM7 ADH7 TRPM3 SEPTIN14 DEF6 ARHGAP29 IFT80 LY75 SEPTIN10 BANK1 SOS1 | 2.33e-04 | 904 | 133 | 13 | EFO_0004736 |
| Disease | response to ranibizumab | 2.99e-04 | 6 | 133 | 2 | EFO_0008348 | |
| Disease | hippocampus volume change measurement, age at assessment | 3.00e-04 | 29 | 133 | 3 | EFO_0008007, EFO_0021492 | |
| Disease | MASA syndrome (implicated_via_orthology) | 4.17e-04 | 7 | 133 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 5.02e-04 | 307 | 133 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | exfoliation syndrome (is_marker_for) | 5.55e-04 | 8 | 133 | 2 | DOID:13641 (is_marker_for) | |
| Disease | prostate cancer (is_marker_for) | 7.23e-04 | 156 | 133 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.44e-04 | 157 | 133 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | response to carboplatin, response to antineoplastic agent | 8.86e-04 | 10 | 133 | 2 | GO_0097327, GO_0097328 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 8.86e-04 | 10 | 133 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | anemia (is_marker_for) | 8.86e-04 | 10 | 133 | 2 | DOID:2355 (is_marker_for) | |
| Disease | total blood protein measurement | 1.01e-03 | 449 | 133 | 8 | EFO_0004536 | |
| Disease | diffuse scleroderma (is_implicated_in) | 1.08e-03 | 11 | 133 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | Primary Ciliary Dyskinesia | 1.26e-03 | 47 | 133 | 3 | C4551720 | |
| Disease | dementia (is_implicated_in) | 1.29e-03 | 12 | 133 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | ghrelin measurement | 1.42e-03 | 49 | 133 | 3 | EFO_0600001 | |
| Disease | mean corpuscular hemoglobin concentration | CUL4A SPTA1 DMXL1 NOP58 ATP11B KIAA1217 RNF20 VPS13A PIP5K1A MACF1 ARRDC3 EIF4G3 LY75 | 1.50e-03 | 1105 | 133 | 13 | EFO_0004528 |
| Disease | Glioblastoma Multiforme | 1.63e-03 | 111 | 133 | 4 | C1621958 | |
| Disease | corpus callosum posterior volume measurement | 1.68e-03 | 52 | 133 | 3 | EFO_0010298 | |
| Disease | alkaline phosphatase measurement | ITIH3 ADH7 SRRT NOP58 BAIAP2L1 RHPN2 IQCB1 TGDS MACF1 EIF4G3 UTRN CNOT1 | 2.18e-03 | 1015 | 133 | 12 | EFO_0004533 |
| Disease | Libman-Sacks Disease | 2.30e-03 | 58 | 133 | 3 | C0242380 | |
| Disease | hemoglobin A1 measurement | 2.53e-03 | 520 | 133 | 8 | EFO_0007629 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 2.62e-03 | 17 | 133 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.62e-03 | 17 | 133 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | electrocardiography | 2.84e-03 | 530 | 133 | 8 | EFO_0004327 | |
| Disease | eosinophil count | UACA SPEF2 C6orf163 CHD7 XPO1 ADD3 RTF1 ADH7 RASGRP1 LMAN1 PLXNC1 NDUFAF6 HABP2 EIF4G3 RSBN1L | 2.95e-03 | 1488 | 133 | 15 | EFO_0004842 |
| Disease | Alzheimer's disease (is_implicated_in) | 3.05e-03 | 132 | 133 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 3.28e-03 | 19 | 133 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Chronic myeloproliferative disorder | 3.28e-03 | 19 | 133 | 2 | C1292778 | |
| Disease | Vertigo | 3.67e-03 | 139 | 133 | 4 | HP_0002321 | |
| Disease | phospholipids:total lipids ratio | 3.74e-03 | 227 | 133 | 5 | EFO_0020946 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 3.93e-03 | 70 | 133 | 3 | EFO_0008082 | |
| Disease | Lupus Erythematosus, Systemic | 4.09e-03 | 71 | 133 | 3 | C0024141 | |
| Disease | temporal horn of lateral ventricle volume measurement | 4.26e-03 | 72 | 133 | 3 | EFO_0010333 | |
| Disease | Seckel syndrome | 4.39e-03 | 22 | 133 | 2 | C0265202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKELKKIFEDFSIQE | 391 | Q8NDB2 | |
| DEFLVKKQDIENILH | 51 | P21399 | |
| EFLAKKFDLDQLITH | 346 | P40394 | |
| FFAHLLQKVLAEEEK | 366 | A6H8Y1 | |
| EEHEVEAEILFQKGK | 2601 | Q96N23 | |
| EIQPEEKHEEFRKLF | 666 | Q8IVF6 | |
| LELAQKKLHDFQDEI | 851 | Q5VTR2 | |
| LEEKHQLKLQFEELE | 51 | Q8TD16 | |
| DKADFKQALKVFHLE | 466 | Q9BXY5 | |
| NDLDRLFVKVEKIHE | 586 | Q07065 | |
| FELKAQFSQILEEHK | 226 | Q7L8J4 | |
| EKLEENHELFSKSFI | 606 | Q9UEY8 | |
| EEFQELVKAKGEELH | 151 | O95267 | |
| REFQEELVDHLKKFS | 631 | A2A2Z9 | |
| VHDIAEKLIKAFAEQ | 336 | Q3MIX3 | |
| EALKEKALVFEHVQS | 1111 | Q8N2N9 | |
| LKKEEQFQEDILREH | 56 | Q5TEZ5 | |
| LDIDHNKKIDFTEFL | 61 | P20930 | |
| LVDFFLKEEHEKLKL | 946 | Q9NQ90 | |
| DKELEAFREELKHFE | 271 | P30533 | |
| AFREELKHFEAKIEK | 276 | P30533 | |
| DIQLKVFDEHKEEDL | 386 | Q9NSV4 | |
| EFFDIIFAELKKKEA | 551 | Q9GZS0 | |
| PKHLNDDVVKIDFED | 56 | Q03135 | |
| AEEKILEEFKETHNA | 1261 | Q9P2D1 | |
| HVFEEDFILNNLEKK | 831 | Q9Y485 | |
| TENQEKKKIFVFLEH | 101 | Q02487 | |
| KLKKEFTVFEHIDIN | 151 | Q96B67 | |
| AENKHVIDFFKKLDI | 441 | Q9NTZ6 | |
| FTVDQDHKVEEFIKS | 386 | Q9Y620 | |
| KLKEDTEFQEFLSVH | 126 | Q9Y4C8 | |
| EVQKKEEVFFNILEH | 136 | Q6ZP01 | |
| EHIFKVEDFDALKDI | 311 | P20702 | |
| RKHAEEKFIEFEDSQ | 96 | O60271 | |
| FIIKHELENLRAKDE | 126 | Q9NW15 | |
| EALKEKALVFEHVQS | 1536 | Q5JPF3 | |
| AVAQLEEEKKHLEFL | 136 | Q9NSK0 | |
| IVKLKHFEKFQDTAE | 41 | Q9Y2X3 | |
| IIVAEFHKKIKEAFE | 146 | Q5VUJ9 | |
| DKNHVIISIDAEKAF | 591 | O00370 | |
| KDFLHKDRDDVNVEI | 426 | Q12791 | |
| HLKDVDFSENALKEV | 451 | Q38SD2 | |
| EKNIKEFLQSFVHIV | 141 | P40933 | |
| HKLVQKRDFLVDDAE | 121 | Q96MC5 | |
| EEAQKQLLHVKVLFD | 1546 | O60486 | |
| DFQDIEHSKAVEILK | 101 | Q5EBL8 | |
| DFLKKIQRVDFDIFH | 296 | Q330K2 | |
| EEFEHFQQELDKKKE | 291 | P49257 | |
| VDEIKEFLHFLTDQF | 691 | O60449 | |
| KFDDVVQAIKDHAFV | 381 | P16885 | |
| LIFAEKKADVDAIHE | 436 | Q9UJV9 | |
| KHLAKAALDFVVEED | 71 | Q8N6N6 | |
| FIIKTVQHKEAEFLQ | 191 | Q99755 | |
| KQLEDILVLAKQFHE | 5446 | Q9UPN3 | |
| KKLHFEKDVDVNLFE | 316 | Q9UKM7 | |
| DEFIVKTVRHKEAEF | 136 | A2A3N6 | |
| EDESFAVKHNKEFLL | 96 | Q13427 | |
| EERAKSQFFEKVHEE | 1401 | O94913 | |
| DFHQKFDLVIKAEQD | 356 | Q96QU1 | |
| KEFIDLAKEIQHVNE | 761 | Q52LW3 | |
| KKEEFHEQSFRVEKI | 381 | Q14520 | |
| ILEHVFFQVVEFKKL | 406 | Q9Y366 | |
| IRDKADEKIIFLFEA | 431 | Q9P2H3 | |
| VSKEFQALIVKHLDE | 166 | Q9Y4C1 | |
| ENFKKFHKEIIHELE | 91 | Q9UHR4 | |
| DAIKKAHIEKDFIAF | 316 | P29466 | |
| LEQLKEAFAKEHQEF | 1071 | P49454 | |
| LDFKDKVDHVIEVCF | 366 | Q13619 | |
| SLNEEIAFLKKVHEE | 231 | P17661 | |
| KQIFQDDKDLVHEFV | 131 | Q2V2M9 | |
| LLDTFKHTDEEFLKQ | 191 | Q9H0C8 | |
| KVFFKIEEKEIEHAL | 531 | Q99741 | |
| KYEEVLHNLEFAKEL | 166 | Q6IMN6 | |
| ILDKVEEGAFVKEHF | 76 | Q9H4E7 | |
| FINAAKAEEKDELLH | 126 | Q15051 | |
| KAEEKDELLHFFQIV | 131 | Q15051 | |
| LFIKVHLEDVFQLFK | 851 | Q9H583 | |
| EFTALEDFVQHKIQK | 66 | Q66K89 | |
| EEFLALKKEDVQLHK | 511 | A2RUR9 | |
| AFLEEKIHLKELYEV | 3451 | Q9NZJ4 | |
| EDVHNFLLEQKLDFI | 1391 | O43432 | |
| NIHKLLDEVFFSEKI | 51 | P25789 | |
| DFKDKVDHIIDICFL | 521 | Q13620 | |
| FLKEAEDFTIFIKNH | 181 | Q93086 | |
| KEALFEQKVRQDIHE | 356 | Q4G0U5 | |
| FEKEILKRDVAHKVF | 131 | Q9UBD0 | |
| HEENIKKLADQFLEE | 176 | Q6P4E1 | |
| LFQEAHEVILKAKDF | 206 | P30711 | |
| QEIKKFLQKHDETIF | 341 | A8MW99 | |
| EDLFKVHDFDVKIDL | 656 | Q92541 | |
| VKAKLDHVQFAEFKI | 786 | Q6PCB5 | |
| QIHVDIEAKKKFDAI | 681 | P46939 | |
| KIDFEEQFLKEKRFH | 396 | Q9C093 | |
| EQFLKEKRFHDQIAV | 401 | Q9C093 | |
| VKIKEEHLAALQFEE | 1346 | Q9C093 | |
| INIVAVKNDHDFLEK | 86 | Q9Y3M8 | |
| KEEAITHFEKLFEVL | 296 | Q9NQ86 | |
| TFKEAEKELQDKFEH | 366 | Q6ZU15 | |
| VELFKFQEEEKSLLH | 141 | P27169 | |
| LTEHNETILFKEKFL | 1666 | O95425 | |
| KKLRAFFVEEEEHFL | 176 | Q5TA31 | |
| DEKFIQKFALFDEKH | 1221 | Q8IZX4 | |
| KQLVKHFEIEVDIFE | 176 | Q06033 | |
| KSVLHIDDKVFAVDQ | 231 | Q8NE18 | |
| EKKNLEFFHEDVRKS | 1176 | Q5T5P2 | |
| EKQLKNEELVIFSFH | 866 | Q7Z333 | |
| KSHFIEIFLEELTKV | 166 | P56182 | |
| EEAEEEVFLKFVILH | 71 | Q86XR7 | |
| KHAFEIILKDENSVI | 511 | Q07889 | |
| KDVDFAVVLKDFILE | 121 | Q8IUC4 | |
| HAEKIEEVKKEVAFF | 736 | Q9BXP5 | |
| QEHDLKLNLKFEIEV | 1271 | A5YKK6 | |
| ENETELIKEHDLFFK | 476 | Q9Y2G3 | |
| HFVKLLFETEKIDIV | 81 | O95455 | |
| KKFIIQDIDDTHVFV | 31 | Q6ZYL4 | |
| FKEHLRDFLVQIKEF | 1011 | O14980 | |
| HIQDFRKEKQEFEEK | 156 | P0CB48 | |
| TEVELFHKDIEAFKE | 2736 | Q96RL7 | |
| AEFNSELKILKEAVH | 2896 | Q8N2C7 | |
| KVKEFFEKLQHTLDQ | 181 | O60858 | |
| EIFLAKIEKFINIHQ | 71 | Q5VVC0 | |
| FHEVKDFEQLVAKLR | 371 | Q0IIM8 | |
| QEKIDKVEDDIFQHF | 766 | Q8NDV3 | |
| LFITDDELKKVHDFE | 1206 | Q9HCF6 | |
| LEHVEVLQKKFEEFQ | 181 | Q13813 | |
| ILEKFALKDVELDFN | 296 | Q6P2S7 | |
| KKDVKLEFFGFEDHE | 421 | Q7Z5K2 | |
| KILEALAKSDEHFVQ | 851 | Q70Z35 | |
| ERTEVLHKKFEDFQV | 191 | P02549 | |
| LHKKFEDFQVELVAK | 196 | P02549 | |
| FSKINEEKIVFFLHL | 196 | O95427 | |
| LKEAERELQAKFEHL | 381 | Q9P0V9 | |
| ELHDVDKAIEFAKEQ | 676 | P49754 | |
| LAEHLQIKEAFEKEV | 1166 | Q9BZF9 | |
| EELFQKHKLSVDEDF | 106 | Q96K49 | |
| FNDEEKERHKVEALA | 91 | Q9NPG3 | |
| NLFFLSEKDVEEHKA | 621 | Q9C0G0 | |
| EQYALREEHIDKVFK | 281 | Q9NUQ3 | |
| EIKFLLHFVKESKQD | 61 | A0A5B0 | |
| FLTEEDQKKLHDFEE | 1161 | Q96QT4 | |
| DSVEQDFHLEIAKKI | 281 | Q6IBS0 | |
| EDRFFEHEVKLNKLA | 291 | P61421 | |
| DDSLVHINIFLVDKK | 1781 | Q5THJ4 | |
| TKEFIINDILKHFQE | 4041 | Q5THJ4 | |
| SFLKKVHEEEIAELQ | 221 | P07196 |